Insights

Strategic Partnerships Quell Therapeutics has established strategic partnerships with prominent companies like AstraZeneca, indicating a strong potential for collaborative sales ventures and cross-selling opportunities in the biotech sector.

Innovative Product Pipeline The company is developing cutting-edge cell-based treatments for autoimmune diseases, a sector with high market demand. This innovative product pipeline presents lucrative sales possibilities for B2B and B2C engagements.

Key Personnel Acquisition By hiring renowned professionals like Luke Devey as the Chief Medical Officer, Quell Therapeutics showcases a commitment to expertise and excellence, enhancing credibility in sales pitches and client interactions.

Financial Stability With revenue in the range of $10M - $50M and significant funding of $156M, Quell Therapeutics exhibits financial stability. This financial robustness can instill confidence in potential partners and investors, optimizing sales negotiations.

Competitive Positioning In a landscape with similar companies like GammaDelta Therapeutics and Immunocore, Quell Therapeutics stands out with its unique focus on cell therapy immunology. Leveraging this distinct positioning can drive competitive advantage and sales differentiation.

Quell Therapeutics Tech Stack

Quell Therapeutics uses 8 technology products and services including jsDelivr, SQLite, ADP, and more. Explore Quell Therapeutics's tech stack below.

  • jsDelivr
    Content Delivery Network
  • SQLite
    Database
  • ADP
    Human Resource Management System
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Google
    Miscellaneous
  • Office 365
    Office Suites
  • Linkedin
    Widgets

Media & News

Quell Therapeutics's Email Address Formats

Quell Therapeutics uses at least 1 format(s):
Quell Therapeutics Email FormatsExamplePercentage
F.Last@quell-tx.comJ.Doe@quell-tx.com
95%
FLast@quell-tx.comJDoe@quell-tx.com
2%
First.Last@quell-tx.comJohn.Doe@quell-tx.com
2%
FirstL@quell-tx.comJohnD@quell-tx.com
1%

Frequently Asked Questions

Where is Quell Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Quell Therapeutics's main headquarters is located at 80 Wood Lane, Translation & Innovation Hub, Imperial College White City Campus, London, London W12 0BZ GB. The company has employees across 5 continents, including EuropeNorth AmericaSouth America.

What is Quell Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Quell Therapeutics's official website is quell-tx.com and has social profiles on LinkedIn.

How much revenue does Quell Therapeutics generate?

Minus sign iconPlus sign icon
As of July 2024, Quell Therapeutics's annual revenue reached $15M.

What is Quell Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Quell Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Quell Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2024, Quell Therapeutics has approximately 155 employees across 5 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Business Officer: L. H.Chief Manufacturing Officer: A. V.Chief Medical Officer: L. D.. Explore Quell Therapeutics's employee directory with LeadIQ.

What industry does Quell Therapeutics belong to?

Minus sign iconPlus sign icon
Quell Therapeutics operates in the Biotechnology Research industry.

What technology does Quell Therapeutics use?

Minus sign iconPlus sign icon
Quell Therapeutics's tech stack includes jsDelivrSQLiteADPjQueryjQuery MigrateGoogleOffice 365Linkedin.

What is Quell Therapeutics's email format?

Minus sign iconPlus sign icon
Quell Therapeutics's email format typically follows the pattern of . Find more Quell Therapeutics email formats with LeadIQ.

How much funding has Quell Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2024, Quell Therapeutics has raised $156M in funding. The last funding round occurred on Nov 29, 2021 for $156M.

When was Quell Therapeutics founded?

Minus sign iconPlus sign icon
Quell Therapeutics was founded in 2019.
Quell Therapeutics

Quell Therapeutics

Biotechnology ResearchLondon, United Kingdom51-200 Employees

An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.

Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively across the business, taking ownership and accountability for the outcomes and results we delivery. Most of all we work with integrity to innovate and bring the best version of ourselves to the job every day. 

Section iconCompany Overview

Headquarters
80 Wood Lane, Translation & Innovation Hub, Imperial College White City Campus, London, London W12 0BZ GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $156M

    Quell Therapeutics has raised a total of $156M of funding over 3 rounds. Their latest funding round was raised on Nov 29, 2021 in the amount of $156M.

  • $10M$50M

    Quell Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $156M

    Quell Therapeutics has raised a total of $156M of funding over 3 rounds. Their latest funding round was raised on Nov 29, 2021 in the amount of $156M.

  • $10M$50M

    Quell Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.